ADPT
Adaptive Biotechnologies Corporation Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$17.30
$-1.20
(-6.49%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $2.64B | EPS (ttm) | $-0.52 | Current Price | $17.30 |
| Enterprise Value | $2.82B | Forward EPS | $-0.58 | Previous Close | $18.50 |
| P/E Ratio | - | ROA | -9.32% | 52W High | $20.76 |
| Forward P/E | -29.68 | ROE | -37.21% | 52W Low | $6.25 |
| PEG Ratio | - | Gross Margin | 65.08% | 50 Day Avg | $17.33 |
| P/S Ratio | 10.45 | Operating Margin | 10.95% | 200 Day Avg | $13.42 |
| P/B Ratio | 12.91 | Profit Margin | -31.50% | Volume | 2.17M |
| EV/EBITDA | -47.00 | Current Ratio | 3.38 | Avg Volume | 2.40M |
| EV/Sales | 11.18 | Quick Ratio | 3.11 | Beta | 2.18 |
| Employees | 619.00 | Debt/Equity | 104.60 | Shares Outstanding | 152.67M |
| Sector | Healthcare | Total Debt | $213.64M | Float Shares | 118.08M |
| Industry | Biotechnology | Total Cash | $212.77M | Short Float | 7.56% |
| Optionable | Yes | Cash/Share | $1.39 | Short Ratio | 4.15 |
| Dividend Yield | - | Book Value/Share | $1.34 | % Held by Insiders | 2.07% |
| Target Price | $20.14 | Revenue (TTM) | $252.75M | % Held by Institutions | 97.74% |